Latest Articles
SETU researcher hopes to ease endometriosis pain with VR - Silicon Republic
SETU researcher hopes to ease endometriosis pain with VR Silicon Republic
Published: June 17, 2025, 6:02 a.m.
Endometriosis linked to higher risk of autoimmune diseases - Contemporary OB/GYN
Endometriosis linked to higher risk of autoimmune diseases Contemporary OB/GYN
Published: June 16, 2025, 6:49 p.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - MSN
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer MSN
Published: June 16, 2025, 11:46 a.m.
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025 - BioSpectrum Asia
Cartherics COO Dr Ian Nisbet on the promise of CAR-NK cells for cancer and endometriosis at BIO 2025 BioSpectrum Asia
Published: June 16, 2025, 11:42 a.m.
Corrigendum: Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity - Frontiers
Corrigendum: Loss of CDYL Results in Suppression of CTNNB1 and Decreased Endometrial Receptivity Frontiers
Published: June 16, 2025, 9:30 a.m.
Exclusive: Naga Munchetty's mother was 'devastated' she decided not to have kids - hellomagazine.com
Exclusive: Naga Munchetty's mother was 'devastated' she decided not to have kids hellomagazine.com
Published: June 16, 2025, 6 a.m.
Exclusive: Naga Munchetty's mother 'devastated' by broadcaster's no-kids decision - hellomagazine.com
Exclusive: Naga Munchetty's mother 'devastated' by broadcaster's no-kids decision hellomagazine.com
Published: June 16, 2025, 6 a.m.
The week ahead: Luxembourg showcases defence at Le Bourget trade fair - Delano.lu
The week ahead: Luxembourg showcases defence at Le Bourget trade fair Delano.lu
Published: June 16, 2025, 4:09 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Insider Monkey
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer Insider Monkey
Published: June 15, 2025, 9:42 a.m.
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer - Yahoo
AstraZeneca’s ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer Yahoo
Published: June 15, 2025, 9:39 a.m.
Link copied to clipboard!